Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Change in Receivables (2016 - 2025)

Vanda Pharmaceuticals' Change in Receivables history spans 16 years, with the latest figure at $4.1 million for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 8.03% to $4.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.5 million, a 42.65% decrease, with the full-year FY2025 number at $7.5 million, down 42.65% from a year prior.
  • Change in Receivables hit $4.1 million in Q4 2025 for Vanda Pharmaceuticals, down from $5.6 million in the prior quarter.
  • Over the last five years, Change in Receivables for VNDA hit a ceiling of $9.1 million in Q2 2023 and a floor of -$9.0 million in Q4 2021.
  • Historically, Change in Receivables has averaged $1.2 million across 5 years, with a median of $2.0 million in 2021.
  • The widest YoY moves for Change in Receivables: up 662.42% in 2023, down 829.85% in 2023.
  • Tracing VNDA's Change in Receivables over 5 years: stood at -$9.0 million in 2021, then soared by 145.16% to $4.1 million in 2022, then increased by 18.79% to $4.8 million in 2023, then decreased by 8.37% to $4.4 million in 2024, then decreased by 8.03% to $4.1 million in 2025.
  • Business Quant data shows Change in Receivables for VNDA at $4.1 million in Q4 2025, $5.6 million in Q3 2025, and $353000.0 in Q2 2025.